Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2024-02-14 00:00:00 ET · period of report 2024-02-12 · accession 0000950170-24-015548 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-14 | 2024-02-12 | IRWD | Davis Andrew | SVP, Chief Business Off | S - Sale | $15.24 | -9,846 | 208.3K | -5% | -$150.1K |
| D | 2024-02-14 | 2024-02-12 | IRWD | Davis Andrew | SVP, Chief Business Off | A - Grant | $0.00 | +65.3K | 273.6K | +31% | $0 |
| D | 2024-02-14 | 2024-02-12 | IRWD | Davis Andrew | SVP, Chief Business Off | A - Grant | $0.00 | +32.7K | 32.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-02-12 | S | D | 9,846 | $15.24 | 208,324 | D | — | — | (F2) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.85 to $15.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. (F3) The reporting person acquired 796 shares of Class A Common Stock under the issuer's employee stock purchase plan on December 31, 2023. |
| 2 | Common | Class A Common Stock | 2024-02-12 | A | A | 65,312 | $0.00 | 273,636 | D | — | — | |
| 3 | Derivative | Performance-based Restricted Stock Unit | 2024-02-12 | A | A | 32,656 | $0.00 | 32,656 | D | — · — to 2027-02-28 | 32,656 Class A Common Stock | (F5) Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share. |